By David Lock2007-10-12T09:00:00
The High Court hearing this year over the issue of the NHS funding drugs for treating Alzheimer's disease forced NICE to state its principles with great clarity. Now it has to stick to them, says David Lock
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud